← All Sponsors
SPONSOR

Genethon

Total Trials
3
Recruiting
3
Phases
Phase 2
Conditions studied: Crigler-Najjar SyndromeDuchenne Muscular Dystrophy
NCT03466463
Recruiting

Gene Therapy for Severe Crigler Najjar Syndrome

Crigler-Najjar Syndrome
France, Italy, Netherlands View Trial →
NCT06518005 Phase 2
Recruiting

Efficacy and Safety of GNT0003 Following Imlifidase Pre-treatment in Severe Crigler-Najjar Syndrome

Crigler-Najjar Syndrome
France View Trial →
NCT03882827
Recruiting

Natural History of Duchenne Muscular Dystrophy

Duchenne Muscular Dystrophy
Belgium, France, Spain View Trial →